Please assess the completion status of the following clinical trial:

Trial Title: Potential Impact of Patient Vitamin D Status in AK Response to MAL-PDT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* male gender~* at least six AKs per field~Exclusion Criteria:~* history of photosensitivity related disorders~* active infectious disease,~* immunosuppression~* laser or any cosmetic treatment in the previous 6 months~* other topical agents in the treatment area such as retinoids, 5-fluorouracil,imiquimod or diclofenac sodium in the previous 3 months~* allergy to MAL or excipients of the cream~* poor patient compliance.

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- Conventional MAL-PDT (Type: OTHER): Conventional topical PDT with Methylaminolevulinate 16% in one half of the scalp with multiple AKs.
- Calcipotriol assisted MAL-PDT (Type: OTHER): Calcipotriol ointment 50 mcg/g applied once a day for 15 consecutive days in one half of the scalp, before Conventional topical PDT

Based on this trial design, predict the completion outcome and termination type (if applicable).